Putting Theory into Practice

Hope S Rees MCP . Why do British women start and stop hormone replacement therapy? Journal of the British Menopause Society 1995; 1(2): 26–7.

Pennell Report on Women's Health 1998. The Pennell Initiative, Health Services Management Unit, University of Manchester, Devonshire House, Precinct Centre, Oxford Road, Manchester, M13 9PL

Royal College of Physicians of London. Osteoporosis. Clinical Guidelines for prevention and treatment 1999

Barrett-Connor E. Hormone replacement therapy. BMJ 1998; 317: 457–61

Hulley S Grady D Bush T Furberg C Herrington D Riggs B Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention ofcoronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–13

Collaborative Group on Hormonal Factors in Breast Cancer. Breast Cancer and HRT: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350: 1047–1059

Hormone replacement therapy and venous thromboembolism. Guideline No 19 1999 The Royal College of Obstetricians and Gynaecologists, London, UK

Pike MC Peters RK Cozen W . Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 1997; 89: 1110–1116

Raloxifene to prevent postmenopausal osteoporosis Drug and Therapeutics Bulletin 1999; 37: 33–36